Aveo Pharmaceuticals Inc (AVEO) - News Archive

Showing 2 of 2 results.

In-depth Analysis of Tivozanib’s Efficacy in Treating Advanced Renal Cell Carcinoma: Long-term Results from the Phase III TIVO-3 Trial

AVEO Oncology recently announced the publication of significant results related to the long-term survival of patients with relapsed or refractory advanced Renal Cell Carcinoma (RCC) who have been treated with Tivozanib....

Feb 6, 2024 Product Service News tivozanib

AVEO Oncology Initiates Pivotal Clinical Trial to Evaluate Ficlatuzumab and ERBITUX Combination Therapy for HPV-Negative Head and Neck Cancer Patients

AVEO Oncology, a subsidiary of LG Chem, has recently commenced enrollment for the FIERCE-HN trial, a highly anticipated phase 3 clinical trial. This global study aims to evaluate the efficacy and safety of AVEO s invest...

Jan 16, 2024 Clinical Study